Last Posted: Oct 17, 2019
- Do Women who Receive a Negative BRCA1/2 Risk Result Understand the Implications for Breast Cancer Risk?
Guan Yue et al. Public health genomics 2019 Oct 1-8 - Population BRCA sequencing; time to move to the next phase?
Gourley Charlie et al. BJOG : an international journal of obstetrics and gynaecology 2019 Oct - A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer.
Sun Li et al. JAMA oncology 2019 Oct - BRCA testing in unaffected young women in the United States, 2006-2017.
Guo Fangjian et al. Cancer 2019 Sep - General “Take Action” Infographic
CDC Cancer, 2019 - Psychosocial problems in women attending French, German and Spanish genetics clinics before and after targeted or multigene testing results: an observational prospective study.
Brédart Anne et al. BMJ open 2019 Sep 9(9) e029926 - Cancer Genetic Counseling and Testing in an Era of Rapid Change.
Hooker Gillian W et al. Journal of genetic counseling 2017 Dec 26(6) 1244-1253 - Gene-panel testing of breast and ovarian cancer patients identifies a recurrent RAD51C duplication.
Pelttari L M et al. Clinical genetics 2018 93(3) 595-602 - Hereditary breast and ovarian cancer.
Barks Phyllis et al. JAAPA : official journal of the American Academy of Physician Assistants 2012 Mar 25(3) 63-5 - Managing hereditary breast cancer risk in women with and without ovarian cancer.
Peters Mary Linton et al. Gynecologic oncology 2017 146(1) 205-214
.png)
No hay comentarios:
Publicar un comentario